Last reviewed · How we verify
Fractionated 5-aminolevulinic acid hydrochloride 20% gel PDT — Competitive Intelligence Brief
marketed
Small molecule
Live · refreshed every 30 min
Target snapshot
Fractionated 5-aminolevulinic acid hydrochloride 20% gel PDT (Fractionated 5-aminolevulinic acid hydrochloride 20% gel PDT) — Maastricht University Medical Center.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Fractionated 5-aminolevulinic acid hydrochloride 20% gel PDT TARGET | Fractionated 5-aminolevulinic acid hydrochloride 20% gel PDT | Maastricht University Medical Center | marketed |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Fractionated 5-aminolevulinic acid hydrochloride 20% gel PDT CI watch — RSS
- Fractionated 5-aminolevulinic acid hydrochloride 20% gel PDT CI watch — Atom
- Fractionated 5-aminolevulinic acid hydrochloride 20% gel PDT CI watch — JSON
- Fractionated 5-aminolevulinic acid hydrochloride 20% gel PDT alone — RSS
Cite this brief
Drug Landscape (2026). Fractionated 5-aminolevulinic acid hydrochloride 20% gel PDT — Competitive Intelligence Brief. https://druglandscape.com/ci/fractionated-5-aminolevulinic-acid-hydrochloride-20-gel-pdt. Accessed 2026-05-18.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab